A prospective study of the incidence of MRSA peristomal infections following gastrostomy insertion and whether infection can be prevented by prophylactic teicoplanin or inserting the tube radiologically.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN37334290

Enrollment

240

Registered

2005-09-30

Start date

2004-06-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: MRSA peristomal infections Signs and Symptoms MRSA peristomal infections

Interventions

Use of intravenous teicoplanin or inserting the gastrostomy tube radiologically rather than endoscopically. Added May 2008: Randomised: 1. RIG + cefotaxime 2. PEG + cefotaxime 3. PEG + teicoplanin

Eligibility

Inclusion criteria

Inclusion criteria: Added May 2008: 1. Subjects over 16 years 2. Referred for PEG/RIG 3. Informed written consent

Exclusion criteria

Exclusion criteria: Added May 2008: 1. Oropharyngeal cancer 2. Already taking antibiotics

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026